Hematology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia Therapy
Data from Himachal Pradesh University, Department of Biotechnology advance knowledge in acute lymphoblastic leukemia therapy
April 16th, 2007
Investigators publish new data in the report "Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. L-Asparaginase is an effective antineoplastic agent, used in the acute lymphoblastic leukemia chemotherapy. It has been an integral part of combination chemotherapy protocols of pediatric acute lymphoblastic leukemia for almost 3 decades," scientists in Shimla, India report. "The potential of L-asparaginase as a drug of leukemia has been a matter of discussion due to the high rate of allergic reactions exhibited by the patients receiving the medication of this enzyme drug. Frequent need of intramuscular injection has been another...
Source: Hematology Week (2007-04-16)
|
